MedTrace Logo

Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care

NCT04748367 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-02-10

No results posted yet for this study

Summary

Paediatric immunization is often associated with significant fear and anxiety among children and their parents. Their distress can greatly affect their future adherence to the immunization schedule and the acceptance of recommended vaccines by physicians. This pilot was a single-centre, open label, randomised controlled trial to examine the use of VR analgesia in childhood immunization in primary care.The study primarily aimed to determine the feasibility of using immersive virtual reality (VR) during immunization in children by assessing the response rate of the participants during recruitment. The secondary outcome of the study was to determine the effectiveness of immersive VR in alleviating pain and anxiety among children during immunization compared to usual care without VR. It also aimed to determine the effectiveness of immersive VR in reducing anxiety among the parents and nurses during immunization procedure.

Conditions

Interventions

DEVICE

Virtual Reality Headset

Virtual Reality Headset running SILVER software

Sponsors & Collaborators

  • Yoozoo Games Co., Ltd

    collaborator UNKNOWN

  • SingHealth DUKE-NUS Family Medicine Academic Clinical Programme (FM ACP)

    collaborator UNKNOWN

  • SingHealth Polyclinics

    lead OTHER

Principal Investigators

  • Zi Ying Chang · SingHealth Polyclinics

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-09
Primary Completion
2020-12-11
Completion
2020-12-11

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04748367 on ClinicalTrials.gov